We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

FDA Probes Off-Label Uses Of Drug-Coated Stents

Law360 (March 12, 2007, 12:00 AM EDT) -- The U.S. Food and Drug Administration reportedly met with a number of bile-duct stent manufacturers on Monday over alleged off-label uses of their products.

Meeting attendees were expected to include Boston...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.